History
| 1972 | Central Research Institute established in the Tokyo office. |
|---|---|
| 1987 | American Peptide Company established in Silicon Valley, CA, U.S.A. |
| 1990 | Central Research Institute moved to Moriya city, Ibaraki pref., Japan. |
| 1991 | “Hemron”, an iron-supply food material, marketed. |
| 1992 | c-GMP facility for pharmaceutical peptide production built. |
| 1995 | “Liver-Hi”, a liver-hydrolysate, marketed. |
| 1996 | “GLUCAGON FOR INJECTION '' ITO '' ”, a formulated pharmaceutical, marketed. |
| 1999 | “ITORELIN”, a formulated buserelin acetate pharmaceutical, marketed. “Sakecalton Inj. 10”, a formulated salmon calcitonin pharmaceutical, marketed. |
| 2000 | Health Science Division established Itoham Foods Inc. |
| 2001 | “ECATLIST Inj. 10U”, a formulated elcatonin pharmaceutical, marketed. “Hemron WS”, a water-soluble heme-iron, marketed. |
| 2002 | c-GMP manufacturing plant of American Peptide Company built in Vista, CA, U.S.A. “MINIHEPA INJECTION 500”, a formulated parnaparin sodium pharmaceutical, marketed. |
| 2003 | Ito Life Sciences, Inc. established in Moriya city, Ibaraki pref., Japan. “VETERINARY ITORELIN INJECTION”, a formulate animal pharmaceutical, marketed. “Hemron SH”, a concentrated heme-iron, marketed. “L-Carnitine”, “L-Carnitine Fumarate” , a functional food ingredient, marketed. |
| 2004 | “RESOLMIN INJECTION 1000”, a formulated dalteparin sodium pharmaceutical, marketed. |
| 2005 | Ito Life Sciences (Shanghai) Co., Ltd. built in Shanghai, China. “ECATLIST Inj. 20U”, a formulated elcatonin pharmaceutical, marketed. |
| 2008 | All the shares of Ito Life Sciences, Inc. including American Peptide Company and Ito Life Sciences (Shanghai) transferred to Otsuka Chemical Company. |
| 2009 | The company name of Ito Life Sciences. Inc. changed to ILS Inc. |
